vimseltinib
deciphera,deciphera
['vimseltinib', 'deciphera']
deciphera pharmaceuticals, inc. presents updated phase 1/2 data for vimseltinib in tgct at the european society for medical oncology (esmo) congress 2022 - 
MD MSC CPDS https://t.co/kePCRsvthW  https://t.co/t7oxnCDRg8  #cardiology  #AI #informatics #healthcare #innovation #entrepreneur RSS feeds